Oligosaccharide nanomedicine of alginate sodium improves therapeutic results of posterior lumbar interbody fusion with cages for degenerative lumbar disease in osteoporosis patients by downregulating serum miR-155

Degenerative lumbar disease (DLD) is a significant issue for public health. Posterior lumbar intervertebral fusion with cages (PLIFC) has high-level fusion rate and realignment on DLD. However, there are some complications following the surgery. Alginate oligosaccharides (AOS) have antioxidant and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yang, Wang, Zhengming, Zhou, Haohan, Kang, Mingyang, Dong, Rongpeng, Zhao, Jianwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703176/
https://www.ncbi.nlm.nih.gov/pubmed/29200854
http://dx.doi.org/10.2147/IJN.S143824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703176/
https://www.ncbi.nlm.nih.gov/pubmed/29200854
http://dx.doi.org/10.2147/IJN.S143824

Ejemplares similares